Below are a series of videos from myeloma experts from Australia, New Zealand and the USA. Each specialist answers questions about a specific part of living with myeloma and amyloidosis.
Click on their name to open the collection of videos from each myeloma expert.
Dr Richardson is a Consultant Haematologist at the Jerome Lipper Myeloma Centre at the Dana-Faber Cancer Institute in Boston, USA and a member of the International Myeloma Working Group.
What do you believe to be the most exciting development in myeloma recently?
What is CAR-T cell therapy and why is it such an exciting development in the treatment for myeloma?
What are bispecific antibodies and antibody conjugates?
What is a monoclonal antibody and how does it treat myeloma?
Professor Ho is Acting Director of Haematology and Director of Research at the Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW. She is also a long-standing member of Myeloma Australia’s Medical and Scientific Advisory Group.
What are the advantages and disadvantages of being on clinical trial?
If I’m looking for a clinical trial online, where would I go?
How do people with myeloma find out more about clinical trials?
Why are clinical trials so important?
Associate Professor Talaulikar is Senior Consultant in Clinical and Laboratory Haematology at Canberra Hospital and Associate Professor at The Australian National University. She is also a long-standing member of Myeloma Australia’s Medical and Scientific Advisory Group
What is a stem cell transplant?
With all the new drugs becoming available, is it still necessary to have a stem cell transplant?
What are some of the long term effects of having a stem cell transplant?
What steps are involved in an autologous stem cell transplant?
Dr Romeril is a Consultant Haematologist at the Bowen Icon Cancer Centre, Wellington, New Zealand and CEO of Myeloma New Zealand. He also sit on Myeloma Australia’s Medical and Scientific Advisory Group.
Risk of renal impairment – do I have a problem and i what I can do to prevent it?
What are complimentary medicines and are they safe to take when someone has myeloma?
Why is it important that people with myeloma have a bone strengthening medication?
How does someone with myeloma reduce their risk of infection?
Dr Gibbs is a Consultant Haematologist at Eastern Health and Alfred Health in Melbourne, Victoria. He is also Director of the Victorian and Tasmanian Amyloidosis Network and a member of Myeloma Australia’s Medical and Scientific Advisory Group